Logo image of CG

CARLYLE GROUP INC/THE (CG) Stock Fundamental Analysis

NASDAQ:CG - Nasdaq - US14316J1088 - Common Stock

55.24  +0.97 (+1.79%)

After market: 55.24 0 (0%)

Fundamental Rating

2

Taking everything into account, CG scores 2 out of 10 in our fundamental rating. CG was compared to 224 industry peers in the Capital Markets industry. CG has a bad profitability rating. Also its financial health evaluation is rather negative. CG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CG had positive earnings in the past year.
In the past year CG has reported a negative cash flow from operations.
Of the past 5 years CG 4 years were profitable.
In multiple years CG reported negative operating cash flow during the last 5 years.
CG Yearly Net Income VS EBIT VS OCF VS FCFCG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B 3B 4B

1.2 Ratios

CG has a Return On Assets of -0.12%. This is in the lower half of the industry: CG underperforms 77.42% of its industry peers.
CG has a worse Return On Equity (-0.50%) than 76.04% of its industry peers.
CG's Return On Invested Capital of 0.73% is on the low side compared to the rest of the industry. CG is outperformed by 78.34% of its industry peers.
Industry RankSector Rank
ROA -0.12%
ROE -0.5%
ROIC 0.73%
ROA(3y)5.62%
ROA(5y)4.32%
ROE(3y)21.44%
ROE(5y)26.61%
ROIC(3y)N/A
ROIC(5y)N/A
CG Yearly ROA, ROE, ROICCG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1.3 Margins

The Operating Margin of CG (2.77%) is worse than 80.65% of its industry peers.
CG has a Gross Margin of 43.87%. This is in the lower half of the industry: CG underperforms 62.21% of its industry peers.
In the last couple of years the Gross Margin of CG has declined.
Industry RankSector Rank
OM 2.77%
PM (TTM) N/A
GM 43.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.75%
GM growth 5Y-9.77%
CG Yearly Profit, Operating, Gross MarginsCG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, CG has about the same amount of shares outstanding.
CG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CG is higher compared to a year ago.
CG Yearly Shares OutstandingCG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
CG Yearly Total Debt VS Total AssetsCG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.86, we must say that CG is in the distress zone and has some risk of bankruptcy.
CG's Altman-Z score of 0.86 is in line compared to the rest of the industry. CG outperforms 49.77% of its industry peers.
A Debt/Equity ratio of 1.57 is on the high side and indicates that CG has dependencies on debt financing.
The Debt to Equity ratio of CG (1.57) is worse than 72.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.57
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACCN/A
WACCN/A
CG Yearly LT Debt VS Equity VS FCFCG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 0.43 indicates that CG may have some problems paying its short term obligations.
With a Current ratio value of 0.43, CG is not doing good in the industry: 74.19% of the companies in the same industry are doing better.
A Quick Ratio of 0.43 indicates that CG may have some problems paying its short term obligations.
With a Quick ratio value of 0.43, CG is not doing good in the industry: 74.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.43
CG Yearly Current Assets VS Current LiabilitesCG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.19% over the past year.
Measured over the past years, CG shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.18% on average per year.
Looking at the last year, CG shows a very strong growth in Revenue. The Revenue has grown by 87.67%.
Measured over the past years, CG shows a small growth in Revenue. The Revenue has been growing by 4.08% on average per year.
EPS 1Y (TTM)6.19%
EPS 3Y16.48%
EPS 5Y21.18%
EPS Q2Q%9.2%
Revenue 1Y (TTM)87.67%
Revenue growth 3Y0.33%
Revenue growth 5Y4.08%
Sales Q2Q%15.25%

3.2 Future

The Earnings Per Share is expected to grow by 10.36% on average over the next years. This is quite good.
The Revenue is expected to grow by 13.67% on average over the next years. This is quite good.
EPS Next Y20.18%
EPS Next 2Y18.69%
EPS Next 3Y15.06%
EPS Next 5Y10.36%
Revenue Next Year12.4%
Revenue Next 2Y17.59%
Revenue Next 3Y13.67%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CG Yearly Revenue VS EstimatesCG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CG Yearly EPS VS EstimatesCG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.34, which indicates a correct valuation of CG.
Compared to the rest of the industry, the Price/Earnings ratio of CG is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.96. CG is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 12.10, which indicates a correct valuation of CG.
The rest of the industry has a similar Price/Forward Earnings ratio as CG.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.11, CG is valued a bit cheaper.
Industry RankSector Rank
PE 15.34
Fwd PE 12.1
CG Price Earnings VS Forward Price EarningsCG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CG.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 81.21
CG Per share dataCG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CG's earnings are expected to grow with 15.06% in the coming years.
PEG (NY)0.76
PEG (5Y)0.72
EPS Next 2Y18.69%
EPS Next 3Y15.06%

3

5. Dividend

5.1 Amount

CG has a Yearly Dividend Yield of 2.68%. Purely for dividend investing, there may be better candidates out there.
CG's Dividend Yield is comparable with the industry average which is at 9.56.
Compared to an average S&P500 Dividend Yield of 2.29, CG has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.68%

5.2 History

The dividend of CG decreases each year by -1.38%.
CG has been paying a dividend for at least 10 years, so it has a reliable track record.
CG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-1.38%
Div Incr Years3
Div Non Decr Years4
CG Yearly Dividends per shareCG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

5.3 Sustainability

The earnings of CG are negative and hence is the payout ratio. CG will probably not be able to sustain this dividend level.
DP-1813.31%
EPS Next 2Y18.69%
EPS Next 3Y15.06%
CG Yearly Income VS Free CF VS DividendCG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B 3B

CARLYLE GROUP INC/THE

NASDAQ:CG (1/17/2025, 8:00:00 PM)

After market: 55.24 0 (0%)

55.24

+0.97 (+1.79%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners60.16%
Inst Owner Change-0.08%
Ins Owners17.92%
Ins Owner Change-1.86%
Market Cap19.76B
Analysts71.54
Price Target57.69 (4.44%)
Short Float %3.57%
Short Ratio3.98
Dividend
Industry RankSector Rank
Dividend Yield 2.68%
Yearly Dividend1.38
Dividend Growth(5Y)-1.38%
DP-1813.31%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.59%
Min EPS beat(2)-8.37%
Max EPS beat(2)1.19%
EPS beat(4)3
Avg EPS beat(4)1.07%
Min EPS beat(4)-8.37%
Max EPS beat(4)7.48%
EPS beat(8)6
Avg EPS beat(8)5.01%
EPS beat(12)9
Avg EPS beat(12)9%
EPS beat(16)13
Avg EPS beat(16)15.34%
Revenue beat(2)0
Avg Revenue beat(2)-5.89%
Min Revenue beat(2)-7.44%
Max Revenue beat(2)-4.35%
Revenue beat(4)1
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-7.44%
Max Revenue beat(4)2.34%
Revenue beat(8)2
Avg Revenue beat(8)-4.85%
Revenue beat(12)4
Avg Revenue beat(12)5.08%
Revenue beat(16)8
Avg Revenue beat(16)54.19%
PT rev (1m)0.89%
PT rev (3m)18.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.25%
EPS NY rev (1m)0.05%
EPS NY rev (3m)0.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.62%
Revenue NY rev (1m)-0.9%
Revenue NY rev (3m)-1.45%
Valuation
Industry RankSector Rank
PE 15.34
Fwd PE 12.1
P/S 3.82
P/FCF N/A
P/OCF N/A
P/B 3.56
P/tB 4.05
EV/EBITDA 81.21
EPS(TTM)3.6
EY6.52%
EPS(NY)4.56
Fwd EY8.26%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS14.47
BVpS15.51
TBVpS13.63
PEG (NY)0.76
PEG (5Y)0.72
Profitability
Industry RankSector Rank
ROA -0.12%
ROE -0.5%
ROCE 0.89%
ROIC 0.73%
ROICexc 0.82%
ROICexgc 1.85%
OM 2.77%
PM (TTM) N/A
GM 43.87%
FCFM N/A
ROA(3y)5.62%
ROA(5y)4.32%
ROE(3y)21.44%
ROE(5y)26.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.75%
GM growth 5Y-9.77%
F-Score3
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 1.57
Debt/FCF N/A
Debt/EBITDA 26.93
Cap/Depr 37.65%
Cap/Sales 1.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.43
Altman-Z 0.86
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)187.86%
Cap/Depr(5y)144.68%
Cap/Sales(3y)5.86%
Cap/Sales(5y)4.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.19%
EPS 3Y16.48%
EPS 5Y21.18%
EPS Q2Q%9.2%
EPS Next Y20.18%
EPS Next 2Y18.69%
EPS Next 3Y15.06%
EPS Next 5Y10.36%
Revenue 1Y (TTM)87.67%
Revenue growth 3Y0.33%
Revenue growth 5Y4.08%
Sales Q2Q%15.25%
Revenue Next Year12.4%
Revenue Next 2Y17.59%
Revenue Next 3Y13.67%
Revenue Next 5YN/A
EBIT growth 1Y-65.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.74%
EBIT Next 3Y16.1%
EBIT Next 5Y15.19%
FCF growth 1Y48.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-166.32%
OCF growth 3YN/A
OCF growth 5YN/A